After covid decline, the pharma and speciality chemical sectors have lost the market fancy. So even the best good companies are available at 30 to 50% discount from their ATH (that doesn’t necessarily mean all of them are available cheap). If conviction is there, then it is time to increase allocation.
Disc: Invested in a basket of companies in these sectors. Tracking Supriya life sciences but no stake yet.
| Subscribe To Our Free Newsletter |
